Researchers have raised concerns about high-potency marijuana and cannabis-induced psychiatric disorders, particularly young ...

The DEA may be close to reaching a decision on rescheduling marijuana to recognize the medical benefits. The DEA spokesman Russ Baer said no determination has been made yet on rescheduling pot, but ...

Duane Boise CEO of MMJ International Holdings stated, “When private citizens or companies fall short of compliance, the DEA acts swiftly ... stalled vital medical marijuana research, it's ...

The DEA is proposing to increase the amount of marijuana that can be legally grown for research by 30% in 2020, a promising sign for cannabis advocates who have long insisted the plant has healing ...

The ordeal began in 2018 when MMJ Biopharma Cultivation submitted its application for a DEA bulk manufacturing registration (grow pharmaceutical marijuana). The company's objective was clear and ...

“While we understand that the DEA may be navigating internal disagreement on this matter, it is critical that the agency swiftly correct marijuana’s misguided placement in Schedule I,” the letter read ...

The ordeal began in 2018 when MMJ Biopharma Cultivation submitted its application for a DEA bulk manufacturing registration (grow pharmaceutical marijuana). The company's objective was clear and ...